Entasis Therapeutics Holdings Inc. (44)
Browse by Contract Category
Contracts
-
Form of Retention Bonus Award Memo
(Filed With SEC on March 3, 2022)
-
Registration Rights Agreement, dated February 18, 2022 by and between the Company and Innoviva
(Filed With SEC on February 18, 2022)
-
Sales Agreement, dated August 27, 2021, between Entasis Therapeutics Holdings Inc. and Cantor Fitzgerald & Co
(Filed With SEC on August 27, 2021)
-
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 11, 2020)
-
Amendment to Nonqualified Stock Option Agreement for senior management under the 2015 Stock Incentive Plan
(Filed With SEC on March 3, 2022)
-
Amendment to Incentive Stock Option Agreement for employees under the 2015 Stock Incentive Plan
(Filed With SEC on March 3, 2022)
-
Amendment to Incentive Stock Option Agreement for senior management under the 2015 Stock Incentive Plan
(Filed With SEC on March 3, 2022)
-
Amendment to Nonqualified Stock Option Agreement for employees under the 2015 Stock Incentive Plan
(Filed With SEC on March 3, 2022)
-
Second Amended Non-Employee Director Compensation Policy, as amended January 1, 2022
(Filed With SEC on March 3, 2022)
-
Amendment to Stock Option Agreements under the 2018 Equity Incentive Plan
(Filed With SEC on March 3, 2022)
-
Amendment to Restricted Stock Unit Agreements under the 2018 Equity Incentive Plan
(Filed With SEC on March 3, 2022)
-
Amended Stock Option Agreement under the 2018 Equity Incentive Plan
(Filed With SEC on March 3, 2022)
-
Amended Restricted Stock Unit Agreement under the 2018 Equity Incentive Plan
(Filed With SEC on March 3, 2022)
-
Securities Purchase Agreement, dated February 17, 2022, by and between the Company and Innoviva
(Filed With SEC on February 18, 2022)
-
Form of Warrant Certificate
(Filed With SEC on February 18, 2022)
-
Convertible Promissory Note, dated February 18, 2022
(Filed With SEC on February 18, 2022)
-
Form of Registration Rights Agreement
(Filed With SEC on May 3, 2021)
-
Securities Purchase Agreement, dated May 3, 2021, by and between the Company and Innoviva
(Filed With SEC on May 3, 2021)
-
Form of Warrant Certificate
(Filed With SEC on May 3, 2021)
-
Form of Restricted Stock Unit Grant Notice (Time-Based)
(Filed With SEC on November 6, 2020)
-
Form of Restricted Stock Unit Grant Agreement
(Filed With SEC on November 6, 2020)
-
Form of Restricted Stock Unit Grant Notice (Performance-Based)
(Filed With SEC on November 6, 2020)
-
Registration Rights Agreement, dated September 1, 2020, by and between the Company and the Investors named therein
(Filed With SEC on September 1, 2020)
-
Securities Purchase Agreement, dated August 27, 2020, by and between the Company and the Investors named therein
(Filed With SEC on September 1, 2020)
-
Form of Pre-Funded Common Stock Purchase Warrant
(Filed With SEC on September 1, 2020)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on September 1, 2020)
-
First Amendment to 2018 Equity Incentive Plan
(Filed With SEC on August 6, 2020)
-
Special Bonus Award Memorandum, dated May 15, 2020
(Filed With SEC on August 6, 2020)
-
Amended Non-employee Director Compensation Policy, as amended December 6, 2019
(Filed With SEC on August 6, 2020)
-
Non-employee Director Compensation Policy, as amended June 19, 2019
(Filed With SEC on May 7, 2020)
-
Employment Agreement between the Company and Eric Kimble, effective September 6, 2019
(Filed With SEC on May 7, 2020)
-
Form of Executive Officer Employment Agreement
(Filed With SEC on May 7, 2020)
-
Registration Rights Agreement, dated April 22, 2020, by and between the Company and Innoviva
(Filed With SEC on April 22, 2020)
-
Investor Rights Agreement, dated April 22, 2020, by and between the Company and Innoviva
(Filed With SEC on April 22, 2020)
-
Form of Investor Rights Agreement
(Filed With SEC on April 13, 2020)
-
Form of Voting Agreement
(Filed With SEC on April 13, 2020)
-
Securities Purchase Agreement, dated April 12, 2020, by and between the Company and Innoviva
(Filed With SEC on April 13, 2020)
-
Form of Registration Rights Agreement
(Filed With SEC on April 13, 2020)
-
Form of Warrant Certificate
(Filed With SEC on April 13, 2020)
-
Non-Employee Director Compensation Policy
(Filed With SEC on March 11, 2020)
-
Registration Rights Agreement, dated as of October 21, 2019, by and between Entasis Therapeutics Holdings Inc. and Aspire Capital Fund, LLC
(Filed With SEC on October 21, 2019)
-
Common Stock Purchase Agreement, dated as of October 21, 2019, by and between Entasis Therapeutics Holdings Inc and Aspire Capital Fund, LLC
(Filed With SEC on October 21, 2019)
-
Novation of Contract, dated January 11, 2019, by and between the Global Antibiotic Research and Development Partnership and the Company
(Filed With SEC on March 29, 2019)
-
Employment Agreement between the Company and Ruben Tommasi, effective September 25, 2018
(Filed With SEC on March 29, 2019)